Grace Therapeutics, Inc. (GRCE)

Grace Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	20.01	22.13	23.01	27.88	30.34	50.94
Short-Term Investments	-	-	-	0.02	13.32	9.79
Cash & Short-Term Investments	20.01	22.13	23.01	27.89	43.66	60.73
Cash Growth	3.07%	-3.79%	-17.52%	-36.12%	-28.11%	326.48%
Other Receivables	0.02	0.13	0.72	0.8	0.55	0.53
Receivables	0.02	0.13	0.72	0.8	0.55	0.53
Prepaid Expenses	0.5	0.45	0.28	0.6	0.72	0.34
Other Current Assets	-	-	-	-	0.35	0.77
Total Current Assets	20.53	22.71	24.01	29.29	45.28	62.37
Property, Plant & Equipment	0.01	0	0.01	0.57	0.57	0.09
Goodwill	8.14	8.14	8.14	8.14	12.96	-
Other Intangible Assets	41.13	41.14	41.15	41.13	69.81	-
Total Assets	69.81	71.99	73.3	79.12	128.62	62.46
Accounts Payable	1.34	0.6	1.01	1.24	1.68	0.12
Accrued Expenses	0.98	1.33	0.68	2.09	1.48	1.38
Current Portion of Leases	-	-	-	0.08	0.1	0.09
Total Current Liabilities	2.32	1.93	1.68	3.41	3.26	1.58
Long-Term Leases	-	-	-	0.41	0.19	-
Long-Term Deferred Tax Liabilities	2.31	2.31	5.51	7.35	16.89	-
Other Long-Term Liabilities	1.63	1.14	4.36	-	0.01	5.22
Total Liabilities	6.26	5.38	11.56	11.17	20.35	6.8
Common Stock	0	0	0	258.29	257.99	197.19
Additional Paid-In Capital	293.64	293.33	278.9	13.97	12.15	10.82
Retained Earnings	-224.05	-220.69	-211.12	-198.27	-155.84	-146.02
Comprehensive Income & Other	-6.04	-6.04	-6.04	-6.04	-6.04	-6.33
Shareholders' Equity	63.55	66.61	61.74	67.96	108.27	55.66
Total Liabilities & Equity	69.81	71.99	73.3	79.12	128.62	62.46
Total Debt	-	-	-	0.49	0.3	0.09
Net Cash (Debt)	20.01	22.13	23.01	27.41	43.37	60.65
Net Cash Growth	3.07%	-3.79%	-16.05%	-36.80%	-28.49%	330.32%
Net Cash Per Share	1.50	1.83	2.41	3.69	7.06	24.54
Filing Date Shares Outstanding	13.83	13.83	9.4	7.44	7.38	4.34
Total Common Shares Outstanding	13.83	13.72	9.4	7.44	7.38	4.34
Working Capital	18.21	20.78	22.33	25.88	42.02	60.79
Book Value Per Share	4.60	4.86	6.57	9.14	14.67	12.82
Tangible Book Value	14.28	17.33	12.46	18.69	25.5	55.66
Tangible Book Value Per Share	1.03	1.26	1.33	2.51	3.45	12.82
Machinery	-	0.01	0.61	0.67	0.7	-

Updated Aug 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q